미국의 조영제 주입기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 유형별, 부문 예측(2025-2030년)

U.S. Contrast Media Injectors Market Trends:

The U.S. contrast media injectors market size was estimated at USD 604.94 million in 2024 and is projected to grow at a CAGR of 10.08% from 2025 to 2030. The market growth is attributed to the rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. The rising number of chronic diseases is driving the demand for diagnostic imaging tests that use conventional imaging methods such as X-rays and ultrasounds, along with advanced imaging techniques such as CT scans and MRIs.

The North America contrast media injectors industry is expected to grow significantly, driven by the rising demand for imaging procedures such as MRI, CT scans, and cardiovascular angiography. This surge is fueled by advancements in imaging technology, an aging population, increasing awareness of preventive healthcare, and the growing prevalence of chronic diseases. Medical imaging is critical in early detection, diagnosis, and treatment planning for a wide range of conditions. According to a study published by the National Library of Medicine in October 2023, nearly 40 million MRI scans are performed annually in the U.S.

In addition, data from the CDC in February 2024 revealed that approximately 129 million Americans are living with at least one major chronic illness. This substantial burden of chronic disease, combined with the high volume of imaging tests performed each year, highlights a strong and growing need for diagnostic imaging, further driving demand for contrast media injectors across the region. Hence, the increasing prevalence of long-term diseases and complex comorbidities is one of the major drivers, as it is leading to an increase in demand for contrast media injectors.

The growing number of product launches and regulatory approvals for contrast media injectors is expected to drive market growth significantly. Companies are introducing advanced technologies, including syringeless and multi-patient injectors, to improve efficiency and patient outcomes. These innovations enhance operational workflows and support better imaging practices, encouraging broader adoption of advanced imaging systems. As a result, the demand for reliable and effective contrast media delivery solutions continues to rise, further fueling market expansion.

U.S. Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. contrast media injectors market report based on product, type, application, and end use:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Injector Systems
  • CT injector systems
  • MRI injector systems
  • Cardiovascular/angiography injector systems
• Consumables
  • Tubing
  • Syringe
  • Others
• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Radiology
• Interventional Cardiology
• Interventional Radiology
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Diagnostics Centers
• Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. U.S. Contrast Media Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/ancillary market outlook.
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing demand for imaging tests
    • 3.3.1.2. Rising launches and approvals of contrast media injectors
    • 3.3.1.3. Increasing prevalence of chronic disorders
    • 3.3.1.4. Growing adoption of syringe less injectors
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Potential complications and risks associated with contrast media injections
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Rising number of distribution agreements
    • 3.3.3.2. Advancements in contrast media injectors
    • 3.3.3.3. Growing clinical trials for contrast media and injectors
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Shortage of radiologists and healthcare professionals
• 3.4. U.S. Contrast Media Injectors Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. U.S. Contrast Media Injectors Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. U.S. Contrast Media Injectors Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 4.5.1. Injector Systems
    • 4.5.1.1. Injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2. CT injector systems
      • 4.5.1.2.1. CT injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.3. MRI injector systems
      • 4.5.1.3.1. MRI injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.4. Cardiovascular/angiography injector systems
      • 4.5.1.4.1. Cardiovascular/angiography injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Consumables
    • 4.5.2.1. Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.2. Syringes
      • 4.5.2.2.1. Syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.3. Tubings
      • 4.5.2.3.1. Tubings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.4. Others
      • 4.5.2.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Contrast Media Injectors Market: Type Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Type Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. U.S. Contrast Media Injectors Market by Type Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 5.5.1. Single Head Injectors
    • 5.5.1.1. Single head injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Dual Head Injectors
    • 5.5.2.1. Dual head injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Syringeless Injectors
    • 5.5.3.1. Syringeless injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Contrast Media Injectors Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Application Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. U.S. Contrast Media Injectors Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 6.5.1. Radiology
    • 6.5.1.1. Radiology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Interventional Cardiology
    • 6.5.2.1. Interventional cardiology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Interventional Radiology
    • 6.5.3.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Contrast Media Injectors Market: End Use Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. End Use Market Share, 2018 & 2030
• 7.3. Segment Dashboard
• 7.4. U.S. Contrast Media Injectors Market by End Use Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 7.5.1. Hospitals
    • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Diagnostics Centers
    • 7.5.2.1. Diagnostics centers market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Ambulatory Surgery Centers
    • 7.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Shenzhen Boon Medical Supply Co., Ltd.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Bracco Diagnostics Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Bayer
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Guerbet
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. ulrich GmbH & Co. KG
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. B.Braun SE
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Shenzhen Antmed Co., Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Ecomed Solutions
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives